Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ADMS

Adamas Pharmaceuticals

$18.20

0.85 (4.90%)

, AGIO

Agios Pharmaceuticals

$65.89

2.51 (3.96%)

05:18
10/15/18
10/15
05:18
10/15/18
05:18
Recommendations
Adamas Pharmaceuticals, Agios Pharmaceuticals, Alnylam, Alexion, Bluebird Bio, BioMarin, CymaBay, Crispr Therapeutics, Global Blood Therapeutics, Horizon Pharma, Jazz Pharmaceuticals, Ocular Therapeutix, Rigel Pharmaceuticals, Xencor analyst commentary at Piper Jaffray »

Piper lists names to own…

ADMS

Adamas Pharmaceuticals

$18.20

0.85 (4.90%)

AGIO

Agios Pharmaceuticals

$65.89

2.51 (3.96%)

ALNY

Alnylam

$82.00

2.51 (3.16%)

ALXN

Alexion

$121.91

2.62 (2.20%)

BLUE

Bluebird Bio

$125.92

-0.81 (-0.64%)

BMRN

BioMarin

$99.60

2.28 (2.34%)

CBAY

CymaBay

$10.19

0.19 (1.90%)

CRSP

Crispr Therapeutics

$37.74

0.85 (2.30%)

GBT

Global Blood Therapeutics

$33.01

1.46 (4.63%)

HZNP

Horizon Pharma

$18.27

0.23 (1.27%)

JAZZ

Jazz Pharmaceuticals

$158.82

3.42 (2.20%)

OCUL

Ocular Therapeutix

$6.09

-0.02 (-0.33%)

RIGL

Rigel Pharmaceuticals

$3.10

0.005 (0.16%)

XNCR

Xencor

$35.08

1.04 (3.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

  • 19

    Oct

  • 19

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 27

    Oct

  • 07

    Nov

  • 27

    Nov

  • 01

    Dec

  • 20

    Dec

  • 28

    Dec

  • 18

    Feb

Friday
NKTR

Nektar

$48.80

0.87 (1.82%)

13:45
10/12/18
10/12
13:45
10/12/18
13:45
Conference/Events
Nektar has a conference call hosted by JPMorgan »

JPMorgan Analyst Fye will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 19

    Oct

  • 07

    Nov

  • 10

    Nov

CYTK

Cytokinetics

$7.46

-0.09 (-1.19%)

08:37
10/12/18
10/12
08:37
10/12/18
08:37
Conference/Events
Cytokinetics management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 18

    Oct

  • 27

    Nov

NKTR

Nektar

$47.93

-0.67 (-1.38%)

04:55
10/12/18
10/12
04:55
10/12/18
04:55
Conference/Events
Nektar has a conference call hosted by JPMorgan »

JPMorgan Analyst Fye will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 19

    Oct

  • 07

    Nov

  • 10

    Nov

Thursday
GILD

Gilead

$72.42

-2.38 (-3.18%)

15:26
10/11/18
10/11
15:26
10/11/18
15:26
Hot Stocks
Gilead to present data from NASH, HBV and HCV programs at Liver Meeting »

Gilead Sciences announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 25

    Oct

  • 07

    Nov

NKTR

Nektar

$48.60

-3.4 (-6.54%)

09:07
10/11/18
10/11
09:07
10/11/18
09:07
Conference/Events
Nektar has a conference call hosted by JPMorgan »

JPMorgan Analyst Fye will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 19

    Oct

  • 07

    Nov

  • 10

    Nov

TBPH

Theravance Biopharma

$30.38

-0.83 (-2.66%)

, MYL

Mylan

$34.59

-0.02 (-0.06%)

08:35
10/11/18
10/11
08:35
10/11/18
08:35
Hot Stocks
Theravance Biopharma, Mylan report 'positive' data from YUPELRI studies »

Theravance Biopharma…

TBPH

Theravance Biopharma

$30.38

-0.83 (-2.66%)

MYL

Mylan

$34.59

-0.02 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 13

    Nov

  • 27

    Nov

  • 18

    Dec

Over a week ago
EXEL

Exelixis

$17.32

-0.29 (-1.65%)

14:42
10/08/18
10/08
14:42
10/08/18
14:42
Recommendations
Exelixis analyst commentary at Piper Jaffray »

Piper Jaffray optimistic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 27

    Nov

  • 14

    Jan

EXEL

Exelixis

$17.61

-0.23 (-1.29%)

08:04
10/08/18
10/08
08:04
10/08/18
08:04
Hot Stocks
Exelixis initiates Phase 3 pivotal trial of cabozantinib »

Exelixis announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 27

    Nov

  • 14

    Jan

TBPH

Theravance Biopharma

$34.33

0.33 (0.97%)

07:33
10/08/18
10/08
07:33
10/08/18
07:33
Hot Stocks
Theravance Biopharma reports 'positive' data from multiple studies of VIBATIV »

Theravance Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 27

    Nov

  • 18

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.